We retrospectively assessed breakthrough invasive fungal infections (b-IFIs) in 100 consecutive patients with leukemia receiving single-agent isavuconazole; 13 had documented b-IFIs (candidiasis in 6, mucormycosis in 4). All b-IFIs were observed in patients with prolonged neutropenia and active leukemia.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454429 | PMC |
http://dx.doi.org/10.1093/cid/ciy406 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!